Key facts
- This page summarizes Quentin McCubbin's Form 4 filing for Frequency Therapeutics, Inc. (KRRO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Jul 2022, 16:50.
Quentin McCubbin - 05 Jul 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)
- Reporting relationship
- Chief Manufacturing Officer
- Issuer ticker
- KRRO
- Reported as of
- 05 Jul 2022
- Net transaction value
- -$9,985
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2022, 16:50:31 UTC
- Prior SEC filing
- 23 Feb 2022
- Next SEC filing
- 19 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ James P. Abely, Attorney-in-Fact for Quentin McCubbin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Quentin McCubbin filed Form 4 for Frequency Therapeutics, Inc. (KRRO) on 07 Jul 2022.
Change
- Previous filing in this sequence was filed on 23 Feb 2022.
- Current net transaction value: -$9,985.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FREQ
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +17,500
- Change %
- +64%
- Price
- Shares after
- 44,909
- Date
- 05 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
FREQ
transaction
Common Stock
Sale
- Transaction value
- $9,985
- Shares
- -6,569
- Change %
- -15%
- Price
- $1.52
- Shares after
- 38,340
- Date
- 06 Jul 2022
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FREQ
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -17,500
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,500
- Exercise price
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
Footnote F2
Includes 4638 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2022.
Footnote F3
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
Footnote F4
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.49 to $1.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Footnote F5
The restricted stock units will vest as to 50% on February 14, 2022 and 50% on July 4, 2022.